phosphorylcholine has been researched along with paclitaxel in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 12 (44.44) | 29.6817 |
| 2010's | 12 (44.44) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Lundberg, BB | 1 |
| Chen, ZB; Chu, IM; Kan, P; Lee, CJ | 1 |
| Adamo, S; Coletti, D; Molinaro, M; Palleschi, S; Silvestroni, L; Tomei, F | 1 |
| Gershlick, A; Hogrefe, K; Javed, Q; Swanson, N | 1 |
| Ishihara, K; Konno, T; Watanabe, J | 1 |
| Feng, SS; Zhao, L | 1 |
| Bozzi, A; Brisdelli, F; Ferretti, A; Iorio, E; Knijn, A; Marcheggiani, D | 1 |
| Banerjee, R; Huilgol, N; Preetha, A | 1 |
| Armes, SP; Craparo, EF; Giammona, G; Lewis, AL; Licciardi, M; Tang, Y | 1 |
| Chen, Z; Chu, H; Jiao, Z; Liu, N; Wang, X | 1 |
| Ando, N; Ishihara, K; Jinno, H; Kitagawa, Y; Konno, T; Miyata, R; Ueda, M | 1 |
| Chiba, N; Ishihara, K; Jinno, H; Kitagawa, Y; Shimada, T; Ueda, M; Wada, M; Watanabe, J | 1 |
| Ishigami, H; Ishihara, K; Kaisaki, S; Kamei, T; Kitayama, J; Konno, T; Nagawa, H; Soma, D; Yamada, J | 1 |
| Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Kandzari, DE; Leon, MB; Miyazawa, A; Sakurai, R; Tsujino, I; Waseda, K; Yock, PG | 1 |
| Kitagawa, Y; Oyama, T; Shimizu, Y; Takeuchi, H; Ueda, M | 1 |
| Emoto, S; Ishigami, H; Ishihara, K; Kaisaki, S; Kamei, T; Kitayama, J; Konno, T; Nagawa, H; Soma, D; Yamaguchi, H | 1 |
| Li, J; Sun, H; Yu, T | 1 |
| Chen, YW; Luo, XL; Qiu, YB; Tu, S; Zhu, K | 1 |
| He, B; Li, Z; Liu, C; Long, L; Sheng, J; Wang, J; Wang, L; Yuan, X | 1 |
| Banerjee, R; Joshi, N; Shanmugam, T; Thakur, A | 1 |
| Hong, Y; Pelinescu, AL; Wagner, WR; Ye, SH | 1 |
| Arora, R; Bahekar, A; Bajaj, A; Bhuriya, R; Khosla, S; Sethi, A; Singh, PP | 1 |
| Bagnoli, M; Canevari, S; De Cecco, L; Granata, A; Iorio, E; Mezzanzanica, D; Nicoletti, R; Pisanu, ME; Podo, F; Ricci, A; Tinaglia, V | 1 |
| Kitagawa, Y; Kitajima, M; Matsuda, S; Oyama, T; Ozawa, S; Takeuchi, H | 1 |
| Ishihara, K; Kikuchi, E; Konno, T; Matsumoto, K; Miyajima, A; Oya, M; Tamura, K | 1 |
| André, N; Berges, R; Borge, L; Bourgarel, V; Braguer, D; Buric, D; Carré, M; Carrier, A; Le Grand, M; Montero, MP; Pasquier, E; Vasseur, S | 1 |
| Dutta, P; Pramanik, D; Singh, JK | 1 |
2 review(s) available for phosphorylcholine and paclitaxel
| Article | Year |
|---|---|
Molecular diagnosis and translymphatic chemotherapy targeting sentinel lymph nodes of patients with early gastrointestinal cancers.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Carriers; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methacrylates; Molecular Diagnostic Techniques; Paclitaxel; Phosphorylcholine; Rats; Stomach Neoplasms | 2010 |
Zotarolimus-eluting stent versus sirolimus-eluting and paclitaxel-eluting stents for percutaneous coronary intervention: a meta-analysis of randomized trials.
Topics: Coated Materials, Biocompatible; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Phosphorylcholine; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Treatment Outcome | 2012 |
1 trial(s) available for phosphorylcholine and paclitaxel
| Article | Year |
|---|---|
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Topics: Aged; Alloys; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Cobalt; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Phosphorylcholine; Prosthesis Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; United States | 2009 |
24 other study(ies) available for phosphorylcholine and paclitaxel
| Article | Year |
|---|---|
Ether lipids enhance the cytotoxic effect of teniposide and paclitaxel in liposomes against leukaemic cells in culture.
Topics: Antineoplastic Agents, Phytogenic; Drug Antagonism; Drug Synergism; Hemolysis; HL-60 Cells; Humans; Jurkat Cells; Liposomes; Paclitaxel; Phospholipid Ethers; Phosphorylcholine; Teniposide | 1997 |
Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Drug Stability; Emulsions; Glycerol; HeLa Cells; Humans; In Vitro Techniques; Mice; Mice, Inbred ICR; Oils; Paclitaxel; Particle Size; Phospholipids; Phosphorylcholine; Polysorbates; Solubility; Surface-Active Agents; Triglycerides | 1999 |
Surface remodeling associated with vasopressin-induced membrane traffic in L6 myogenic cells.
Topics: Acridine Orange; Acrylamide; Androstadienes; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line; Cell Membrane; Cell Movement; Cytochalasin B; Enzyme Inhibitors; Exocytosis; Fluorescent Dyes; Fluorometry; Kinetics; Ligands; Microscopy, Electron; Microscopy, Electron, Scanning; Muscles; Paclitaxel; Phosphatidylcholines; Phosphatidylinositol 3-Kinases; Phospholipids; Phosphorylcholine; Rats; Signal Transduction; Time Factors; Vasopressins; Wortmannin | 2000 |
Human internal mammary artery organ culture model of coronary stenting: a novel investigation of smooth muscle cell response to drug-eluting stents.
Topics: Cell Division; Coated Materials, Biocompatible; Coronary Artery Disease; Drug Delivery Systems; Graft Occlusion, Vascular; Humans; Mammary Arteries; Models, Cardiovascular; Muscle, Smooth, Vascular; Organ Culture Techniques; Paclitaxel; Phosphorylcholine; Recurrence; Stents | 2002 |
Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers.
Topics: Antineoplastic Agents, Phytogenic; Biocompatible Materials; Drug Stability; Ethanol; Methacrylates; Paclitaxel; Phosphorylcholine; Solubility; Solutions; Solvents; Spectrometry, Fluorescence; Water | 2003 |
Effects of lipid chain unsaturation and headgroup type on molecular interactions between paclitaxel and phospholipid within model biomembrane.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Kinetics; Membranes, Artificial; Paclitaxel; Phosphatidylethanolamines; Phospholipids; Phosphorylcholine; Thermodynamics | 2005 |
Metabolic alterations in K562 cells exposed to taxol and tyrphostin AG957: 1H NMR and biochemical studies.
Topics: Antineoplastic Agents, Phytogenic; Buthionine Sulfoximine; Glutathione; Humans; Inositol; K562 Cells; Lipid Metabolism; Magnetic Resonance Spectroscopy; Models, Statistical; Paclitaxel; Phospholipids; Phosphorylcholine; Time Factors; Tyrphostins | 2005 |
Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Membrane Permeability; Drug Combinations; Fatty Alcohols; Female; Fluoresceins; Fluorescent Dyes; Humans; In Vitro Techniques; Liposomes; Membrane Fluidity; Membranes, Artificial; Models, Biological; Paclitaxel; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Surface-Active Agents; Uterine Cervical Neoplasms | 2007 |
in vitro biological evaluation of folate-functionalized block copolymer micelles for selective anti-cancer drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Caco-2 Cells; Drug Delivery Systems; Folic Acid; Humans; K562 Cells; Micelles; Paclitaxel; Phosphorylcholine; Polymethacrylic Acids; Tamoxifen | 2008 |
Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC-b-PBMA copolymer.
Topics: Antineoplastic Agents, Phytogenic; Drug Carriers; Emulsions; Kinetics; Magnetic Resonance Spectroscopy; Methacrylates; Micelles; Molecular Weight; Nanoparticles; Paclitaxel; Particle Size; Phosphorylcholine; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2009 |
Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Carriers; Drug Screening Assays, Antitumor; Female; Hepatitis B Surface Antigens; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Paclitaxel; Phosphorylcholine; Protein Precursors; Tissue Distribution | 2009 |
Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Delivery Systems; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Infusions, Subcutaneous; Methacrylates; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Phosphorylcholine; Tissue Distribution; Tumor Cells, Cultured | 2009 |
Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Carriers; Female; Humans; Injections, Intraperitoneal; Methacrylates; Mice; Mice, Nude; Paclitaxel; Peritoneal Neoplasms; Phosphorylcholine; Stomach Neoplasms; Tissue Distribution; Xenograft Model Antitumor Assays | 2009 |
Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Female; Humans; Injections, Intraperitoneal; Liver; Methacrylates; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Peritoneal Neoplasms; Phosphorylcholine; Solubility; Tissue Distribution | 2011 |
Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: more than just AKT inhibition.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Survival; Ceramides; Drug Synergism; Female; HT29 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Paclitaxel; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; RNA Interference; Signal Transduction; TOR Serine-Threonine Kinases | 2011 |
Enhancement of cellular uptake and antitumor efficiencies of micelles with phosphorylcholine.
Topics: Antineoplastic Agents; Cell Death; Endocytosis; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Methacrylates; Micelles; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Paclitaxel; Phosphorylcholine; Polyesters; Polymethacrylic Acids | 2011 |
Hollow poly(MPC-g-PEG-b-PLA) graft copolymer microcapsule as a potential drug carrier.
Topics: Adsorption; Animals; Antineoplastic Agents; Biocompatible Materials; Biomimetics; Capsules; Cattle; Drug Carriers; Drug Delivery Systems; Electron Probe Microanalysis; Humans; Lactic Acid; Methacrylates; Paclitaxel; Phosphorylcholine; Polyesters; Polyethylene Glycols; Polymers; Polymethacrylic Acids; Serum Albumin, Bovine | 2012 |
Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: Implications for glioblastoma multiforme therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Synergism; Female; Glioblastoma; Humans; Male; Nanostructures; Paclitaxel; Phosphorylcholine; Rats; Rats, Wistar | 2013 |
Synthesis, characterization, and paclitaxel release from a biodegradable, elastomeric, poly(ester urethane)urea bearing phosphorylcholine groups for reduced thrombogenicity.
Topics: Animals; Biocompatible Materials; Blood Platelets; Cell Proliferation; Drug Carriers; Drug-Eluting Stents; Elasticity; Elastomers; Hydroxy Acids; Myocytes, Smooth Muscle; Paclitaxel; Phosphorylcholine; Polyesters; Polymers; Propionates; Rats; Sheep; Tensile Strength; Vascular Grafting | 2012 |
Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Choline; Choline Kinase; Down-Regulation; Doxorubicin; Female; Humans; Lipid Metabolism; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Phosphorylcholine; Platinum; RNA Interference; Signal Transduction; Transcriptome | 2014 |
Translymphatic chemotherapy targeting sentinel lymph nodes using a novel phospholipid polymer-Paclitaxel conjugate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Lymph Nodes; Lymphatic Metastasis; Male; Methacrylates; Neoplasms; Paclitaxel; Phosphorylcholine; Rats; Sentinel Lymph Node Biopsy | 2014 |
Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.
Topics: Administration, Intravesical; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Methacrylates; Mice, Inbred C3H; Neoplasm Transplantation; Paclitaxel; Phosphorylcholine; Solubility; Tumor Burden; Urinary Bladder Neoplasms | 2015 |
Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Culture Techniques; Cell Cycle Checkpoints; Cell Line, Tumor; Disease Models, Animal; Energy Metabolism; Glycolysis; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Mice; Mitochondria; Paclitaxel; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Phase Behavior of Pure PSPC and PEGylated Multicomponent Lipid and Their Interaction with Paclitaxel: An All-Atom MD Study.
Topics: Lipid Bilayers; Paclitaxel; Phase Transition; Phosphatidylcholines; Phosphorylcholine; Polyethylene Glycols | 2021 |